(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 145.38% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.18%.
Cibus's revenue in 2025 is $4,262,000.On average, 2 Wall Street analysts forecast CBUS's revenue for 2025 to be $341,103,285, with the lowest CBUS revenue forecast at $166,944,810, and the highest CBUS revenue forecast at $515,261,760. On average, 2 Wall Street analysts forecast CBUS's revenue for 2026 to be $1,018,157,238, with the lowest CBUS revenue forecast at $215,722,924, and the highest CBUS revenue forecast at $1,820,591,552.
In 2027, CBUS is forecast to generate $2,256,674,755 in revenue, with the lowest revenue forecast at $1,662,234,438 and the highest revenue forecast at $2,851,115,072.